Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
US Weekly on MSN7d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
While ketamine is celebrated as a breakthrough depression treatment, new research highlights a significant rise in its ...
Recreational ketamine use has local researchers sounding the alarm. Dr. Philip Botkiss is the medical director of the West Coast Ketamine Center. He says he's seen a good response from patients ...
Jeni Larmour died after taking ketamine on her first night at Newcastle University back in September 2020. Sandra Larmour, Jeni’s mum, is now calling for the reclassification of the drug, claiming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback